Claritas Rx is a healthcare technology company founded in 2011 in South San Francisco. It builds software that unifies fragmented data from specialty pharmacies, distributors, and hubs, then applies artificial intelligence and predictive modelling to surface barriers in the specialty pharmaceutical supply chain.
The company's main product, Claritas Rx Ascend, aggregates disparate patient and prescription data sets and runs predictive models to flag access issues before they disrupt care. Reported performance metrics include 95% patient match accuracy and a 20% increase in fill rates for complex cases.
Claritas Rx serves clients across specialty pharmaceuticals, biopharma, and rare disease. The firm grew out of a small channel data consultancy into a platform provider whose stated focus is improving outcomes along the patient journey.